Acquisitions11 Mar 2025, 06:51 pm
Zydus Lifesciences to Acquire 85.6% Stake in Amplitude Surgical SA for Euro 256.8 Million
AI Summary
Zydus Lifesciences Limited, a Gujarat-based pharmaceutical company, has approved the acquisition of a controlling stake in Amplitude Surgical SA, a listed entity in France. The acquisition will be made through a Put Option Agreement, Share Purchase Agreements, and other agreements. The deal is valued at Euro 256.8 million for 85.6% equity shares of the Target Entity. Post-acquisition, Zydus intends to file a mandatory simplified cash tender offer for the remaining shares and delist the Target Entity, subject to regulatory approvals.
Key Highlights
- Zydus Lifesciences to acquire 85.6% stake in Amplitude Surgical SA for Euro 256.8 million
- The acquisition will be made through a Put Option Agreement, Share Purchase Agreements, and other agreements
- Post-acquisition, Zydus intends to file a mandatory simplified cash tender offer for the remaining shares and delist the Target Entity
- Amplitude Surgical SA is a leading entity in the orthopaedics market with a global reach and high-quality products
- The acquisition is expected to enhance Zydus's global MedTech strategy and provide an opportunity to leverage the Target Entity’s strengths in the global markets